Clinical Epigenetics,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Oct. 11, 2023
Previous
studies
have
traditionally
attributed
the
initiation
of
cancer
cells
to
genetic
mutations,
considering
them
as
fundamental
drivers
carcinogenesis.
However,
recent
research
has
shed
light
on
crucial
role
epigenomic
alterations
in
various
cell
types
present
within
tumor
microenvironment,
suggesting
their
potential
contribution
formation
and
progression.
Despite
these
significant
findings,
progress
understanding
epigenetic
mechanisms
regulating
heterogeneity
been
impeded
over
past
few
years
due
lack
appropriate
technical
tools
methodologies.The
emergence
single-cell
sequencing
enhanced
our
governing
by
revealing
distinct
layers
individual
(chromatin
accessibility,
DNA/RNA
methylation,
histone
modifications,
nucleosome
localization)
diverse
omics
(transcriptomics,
genomics,
multi-omics)
at
level.
These
technologies
provide
us
with
new
insights
into
molecular
basis
intratumoral
help
uncover
key
events
driving
development.This
paper
provides
a
comprehensive
review
emerging
analytical
experimental
approaches
omics,
focusing
specifically
epigenomics.
capture
integrate
multiple
dimensions
cells,
thereby
features.
Additionally,
this
outlines
future
trends
current
limitations.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: April 11, 2023
Cancer
immunotherapy
is
the
great
breakthrough
in
cancer
treatment
as
it
displayed
prolonged
progression-free
survival
over
conventional
therapies,
yet,
to
date,
only
a
minority
of
patients.
In
order
broad
clinical
applicability
some
roadblocks
need
be
overcome,
first
among
all
lack
preclinical
models
that
faithfully
depict
local
tumor
microenvironment
(TME),
which
known
dramatically
affect
disease
onset,
progression
and
response
therapy.
this
review,
we
provide
reader
with
detailed
overview
current
3D
developed
mimick
complexity
dynamics
TME,
focus
on
understanding
why
TME
major
target
anticancer
We
highlight
advantages
translational
potentials
spheroids,
organoids
immune
Tumor-on-a-Chip
modeling
therapeutic
response,
while
outlining
pending
challenges
limitations.
Thinking
forward,
possibility
integrate
know-hows
micro-engineers,
immunologists,
pharmaceutical
researchers
bioinformaticians
meet
needs
clinicians
interested
using
these
platforms
high
fidelity
for
patient-tailored
drug
discovery.
Oxford Open Immunology,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Jan. 1, 2023
Abstract
‘Exhaustion’
is
a
term
used
to
describe
state
of
native
and
redirected
T-cell
hypo-responsiveness
resulting
from
persistent
antigen
exposure
during
chronic
viral
infections
or
cancer.
Although
well-established
phenotype
across
mice
humans,
exhaustion
at
the
molecular
level
remains
poorly
defined
inconsistent
literature.
This
is,
in
part,
due
an
overreliance
on
surface
receptors
define
these
cells
explain
exhaustive
behaviours,
incomplete
understanding
how
arises,
lack
clarity
over
whether
same
contexts,
e.g.
versus
With
development
systems-based
genetic
approaches
such
as
single-cell
RNA-seq
CRISPR
screens
applied
vivo
data,
we
are
moving
closer
consensus
view
exhaustion,
although
it
arises
challenging
given
difficulty
manipulating
setting.
Accordingly,
producing
studying
exhausted
T-cells
ex
burgeoning,
allowing
experiments
be
conducted
scale
up
with
high
throughput.
Here,
first
review
what
currently
known
about
it’s
being
studied.
We
then
discuss
improvements
their
method
isolation/production
examining
impact
different
microenvironmental
signals
cell
interactions
have
now
become
active
area
research.
Finally,
future
holds
for
analysis
this
physiological
condition
and,
diversity
ways
which
generated,
propose
adoption
unified
approach
clearly
defining
using
set
metabolic-,
epigenetic-,
transcriptional-,
activation-based
phenotypic
markers,
that
call
‘M.E.T.A’.
Clinical Epigenetics,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Oct. 11, 2023
Previous
studies
have
traditionally
attributed
the
initiation
of
cancer
cells
to
genetic
mutations,
considering
them
as
fundamental
drivers
carcinogenesis.
However,
recent
research
has
shed
light
on
crucial
role
epigenomic
alterations
in
various
cell
types
present
within
tumor
microenvironment,
suggesting
their
potential
contribution
formation
and
progression.
Despite
these
significant
findings,
progress
understanding
epigenetic
mechanisms
regulating
heterogeneity
been
impeded
over
past
few
years
due
lack
appropriate
technical
tools
methodologies.The
emergence
single-cell
sequencing
enhanced
our
governing
by
revealing
distinct
layers
individual
(chromatin
accessibility,
DNA/RNA
methylation,
histone
modifications,
nucleosome
localization)
diverse
omics
(transcriptomics,
genomics,
multi-omics)
at
level.
These
technologies
provide
us
with
new
insights
into
molecular
basis
intratumoral
help
uncover
key
events
driving
development.This
paper
provides
a
comprehensive
review
emerging
analytical
experimental
approaches
omics,
focusing
specifically
epigenomics.
capture
integrate
multiple
dimensions
cells,
thereby
features.
Additionally,
this
outlines
future
trends
current
limitations.